Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

HIV Infections 6Acquired Immunodeficiency Syndrome 6Sarcoma, Kaposi 5Melanoma 4Carcinoma, Renal Cell 4Tumor Virus Infections 1Neuroendocrine Tumors 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Kidney Neoplasms 1Hematologic Neoplasms 1Anus Neoplasms 1Adult Solid Neoplasm 1AIDS-Related Complex 1

Interventions

Isotretinoin 1Interferon alpha-2 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Tumor Virus Infections × Interferon alpha-2 × Clear all
NCT00000764 2021-10-28

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
98 enrolled
Gastrointestinal

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Anus Neoplasms, Tumor Virus Infections, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡